Home/Filings/4/0001437749-20-012740
4//SEC Filing

Latour Wouter 4

Accession 0001437749-20-012740

CIK 0000072444other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:38 PM ET

Size

5.9 KB

Accession

0001437749-20-012740

Insider Transaction Report

Form 4
Period: 2020-06-08
Latour Wouter
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-08+900,000900,000 total
    Exercise: $1.70Exp: 2030-03-23Common Stock (900,000 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the board of directors of Vaxart, Inc. on March 24, 2020, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 8, 2020.
  • [F2]The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on the date of grant, and thereafter in 24 equal monthly installments commencing on the first day of the calendar month following the grant date such that the stock option shall be fully vested on April 1, 2022.

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001652203

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:38 PM ET
Size
5.9 KB